Cargando…

Contemporary RNA Therapeutics for Glioblastoma

Glioblastoma (GBM) is the most common primary brain tumor in adults and is universally lethal with a median survival of less than two years with standard therapy. RNA-based immunotherapies have significant potential to establish a durable treatment response for malignant brain tumors including GBM....

Descripción completa

Detalles Bibliográficos
Autores principales: Melnick, Kaitlyn, Dastmalchi, Farhad, Mitchell, Duane, Rahman, Maryam, Sayour, Elias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186014/
https://www.ncbi.nlm.nih.gov/pubmed/34101090
http://dx.doi.org/10.1007/s12017-021-08669-9